Additionally, Previous evidence had shown thatS100A7 could interact with advanced glycosylation end product receptor (RAGE) and Toll-like receptor 4 (TLR4), thereby exerting paracrine effects and promoting the infiltration of macrophage in breast cancer [35]. Here, AGER is linked to breast carcinoma.